Researchers at the University of Arizona have developed a new method for cancer phenotyping using label-free optical microscopy coupled with a deep learning artificial intelligence (AI) algorithm.

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

MarketThe global MRI (Magnetic Resonance Imaging) Market is valued at USD 8.15 Billion in 2024 and is projected to reach a ...

In a significant milestone for global healthcare innovation, the World Health Organization (WHO) has released a technical ...

In a significant step towards global healthcare innovation, the World Health Organization (WHO) has released a technical ...

The Boston-based digital pathology firm's updated US Food and Drug Administration clearance will help it to quickly validate its software with new hardware combinations.

Ultrasound (US) imaging is a widely employed diagnostic tool used for real-time imaging of various organs and tissues using ...

The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...

Conventional handheld photoacoustic and ultrasound Imaging (PAUS), while offering flexibility, offers only a narrow view of the target region, providing limited information on its structure.

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed a groundbreaking AI technology that ...